Opioid use disorder (OUD) remains a major public health challenge in the United States, and medication-assisted treatment with buprenorphine, a μ-opioid receptor partial agonist, is a cornerstone of effective management. Currently marketed long-acting bupreno... ...

请注册登录后继续浏览